CHELSEA LYNN JECMENEK

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant LA GRANGE, TX NPI 1770916397

General Payments — all program years on this page

$7,104.04

  • Category: General Payments
  • Program years: PY2021
  • Record count: 14
  • As of (CMS publication): 2026-01-23

Latest program year (PY2021): $7,104.04 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2021) · sorted by reported total.

By paying entity

Latest program year (PY2021) · sorted by reported total.

Paying entityAmountRecords
Genentech USA, Inc. $6,990.4713
Genentech, Inc. $113.571

By program year

Program yearAmountRecords
2021 $7,104.0414

Records — PY2021 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
836014287 Genentech USA, Inc. $440.00 02/23/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
836014291 Genentech USA, Inc. $750.00 01/26/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
836014293 Genentech USA, Inc. $6.44 10/01/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
836014297 Genentech USA, Inc. $1,250.00 10/27/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
836014299 Genentech USA, Inc. $106.78 10/27/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
836014303 Genentech USA, Inc. $40.32 10/27/2021 Travel and Lodging Undisputed 01/23/2026 View at CMS
836014305 Genentech USA, Inc. $2,000.00 11/17/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
836014309 Genentech USA, Inc. $72.65 11/17/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
836014311 Genentech USA, Inc. $143.36 11/17/2021 Travel and Lodging Undisputed 01/23/2026 View at CMS
836014315 Genentech USA, Inc. $15.92 07/07/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
836014317 Genentech USA, Inc. $2,000.00 12/07/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
836014321 Genentech USA, Inc. $79.88 12/07/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
836014323 Genentech USA, Inc. $85.12 12/07/2021 Travel and Lodging Undisputed 01/23/2026 View at CMS
836014327 Genentech, Inc. $113.57 08/25/2021 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.